HSIC
50
-3
TRIP
66
5
DIS
60
2
EMC
53
-3
MCD
67
2
HSY
40
2
C
60
-2
AVB
65
-2
IR
72
-5
QCOM
55
-4
WMB
60
4
PYPL
43
-4
WAT
54
2
THC
61
-3
MSI
72
2
GPC
37
-14
AIV
71
9
SYF
65
-6
NAVI
55
-2
BBY
56
-2
HSIC
50
-3
TRIP
66
5
DIS
60
2
EMC
53
-3
MCD
67
2
HSY
40
2
C
60
-2
AVB
65
-2
IR
72
-5
QCOM
55
-4
WMB
60
4
PYPL
43
-4
WAT
54
2
THC
61
-3
MSI
72
2
GPC
37
-14
AIV
71
9
SYF
65
-6
NAVI
55
-2
BBY
56
-2
Financhill
Back

LM Funding America Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
44

LMFA
LM Funding America

Last Price:
2.48
Seasonality Move:
-27.15%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
44
LM Funding America (LMFA) is a Sell

Is LM Funding America a Buy, Sell or Hold?

  • The current LM Funding America [LMFA] share price is $2.45. The Score for LMFA is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • LMFA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

LMFA Stock Price Chart

What is LM Funding America's stock price today?

  • The LM Funding America share price today is $2.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LMFA is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

LMFA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 40.97 Sell
Chaikin Money Flow: -10138 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.42 - 2.92) Sell
Bollinger Bands (100): (2.53 - 4.41) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

LMFA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.48 Sell
20-day SMA: 2.59 Sell
50-day SMA: 3.21 Sell
200-day SMA: 3.25 Sell
8-day EMA: 2.49 Sell
20-day EMA: 2.62 Sell
50-day EMA: 3.02 Sell
200-day EMA: 3.38 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

LM Funding America Earnings Growth & LMFA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.70 per share, an increase this year of $1.61 per share, and an increase next year of $0.65 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

LM Funding America Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):